Skip to content

Multi-carbapenemase-producing Klebsiella pneumoniae: Genomic characterization and In Vitro evaluation of cefiderocol and novel β-lactam/β-lactamase inhibitor combinations

Oct 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 42 references
Medicine

TL;DR

The preserved activity of aztreonam/avibactam and cefepime/zidebactam, alongside the observed synergistic combinations, underscores promising therapeutic strategies for managing infections caused by these highly resistant pathogens.

View source

Similar papers

Sep 2026

Genomic Characterisation of Carbapenem-Resistant Klebsiella pneumoniae and Enterobacter hormaechei Clinical Isolates from Nigeria: Evidence of Resistance, Virulence, and Putative Plasmid-Mediated Gene Sharing

Describing clinically relevant resistance and virulence determinants in three purposively selected carbapenem-resistant Enterobacterales from Nigerian tertiary-care hospitals identifies possible plasmid-mediated gene sharing.

S. Akinde, A. A. Adesoye, Olabisi O. Ojo et al. · 0 citations
Open access Aug 2026

Triple carbapenemase-producing Klebsiella pneumoniae ST6668 resistant to novel β-lactam/β-lactamase inhibitor combinations and cefiderocol, Northern Italy, 2025.

Klebsiella pneumoniae ST6668 has recently emerged in Northern Italy, but data on its resistance architecture remain limited. We identified a K. pneumoniae ST6668 (KNVO1) strain co-producing NDM-1, VIM-1 and OXA-48 carbapenemases, via multiple megaplasmids, from an elderly hospitalized patient who experienced clinical d...

V. Marchetti, Nicole Giorgi, Francesca Piscopiello et al. · 0 citations
Open access Aug 2026

The Evolving Clonal, Plasmid-Mediated Resistome, Virulome and Therapeutic Landscape of Carbapenem-Resistant Klebsiella pneumoniae in Oman

Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) increasingly combines high-risk clonal expansion, mobile resistance platforms and limited treatment options. We investigated the genomic epidemiology, resistance and virulence architecture, plasmid backbones, and therapeutic vulnerabilities of CRKP circulati...

Arwa Al Rujaibi, Zaaima Al-Jabri, Azza Mohammed Al Mamari et al. · 0 citations
Open access Aug 2026

Beyond Carbapenemases: Chromosomal Resistance Mechanisms and Carbapenemase Type Determine Susceptibility to Novel β-Lactam/β-Lactamase Inhibitor Combinations and Cefiderocol in Carbapenem-Resistant Pseudomonas aeruginosa from China

Background: β-lactam/β-lactamase inhibitor combinations (BL/BLIs) and siderophore cephalosporin serve as critical polymyxin alternatives for carbapenem-resistant Pseudomonas aeruginosa (CRPA). However, systematic multicenter clinical data from China and the resistance mechanisms underlying non-susceptibility to these a...

Jian-Kang Zhao, Yan-Yan Fan, Bin Cao · 1 citation
Open access Aug 2026

Molecular Characterization and Resistance Gene Co-occurrence in Carbapenem-Resistant Klebsiella peumoniae from a Bangkok Tertiary Hospital, Thailand.

INTRODUCTION Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a significant global health concern due to its high morbidity and mortality rates and limited treatment options. We investigated the molecular characteristics and co-occurrence of resistance genes in CRKP isolates from a tertiary hospital in Bangkok, Tha...

A. Pootong, Sidaporn Saiaut, Naipapron Dinmuang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.